Skip to main content
    I

    Incannex Healthcare Inc. (IXHL)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $1.93
    -0.04 (-2.03%)

    Market Cap: $24.72M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Earnings

    Upcoming Estimates

    Reports Feb 11, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-0.53
    Range-0.53 - -0.53
    1 analysts
    EPS Revisions
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-0.60+10.6%
    60d ago-0.60+10.6%
    30d ago-0.60+10.6%
    7d ago-0.60+10.6%
    Current-0.53
    Revenue Consensus
    N/A
    RangeN/A
    2 analysts
    Last 12 of 15 reported quarters and 1 upcoming estimate
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    Exp. Feb 11
    --0.53-0.53 - -0.53--1
    1
    0
    30d
    -
    Sep 26
    Reported Nov 12
    -0.15-0.66N/A--1
    0
    1
    30d
    -
    Jun 26
    Reported Sep 25
    -0.140.13-0.54 - 0.18--2
    No revisions (30d)
    -
    Mar 26
    Reported May 15
    -0.49-0.84-0.84 - -0.84--1
    1
    0
    30d
    -
    Dec 25
    Reported Feb 13
    -0.85-0.93-0.93 - -0.93--1
    1
    0
    30d
    -
    Sep 25
    Reported Nov 14
    -0.92-18.09N/A--1
    1
    0
    30d
    -
    Jun 25
    Reported Sep 29
    -0.78-0.45-0.45 - -0.45--1
    1
    0
    30d
    -
    Mar 25
    Reported May 15
    -0.24-0.46N/A--0
    No revisions (30d)
    -
    Dec 24
    Reported Feb 14
    -15.56-20.43N/A--0
    No revisions (30d)
    -
    Sep 24
    Reported Nov 14
    -13.41-21.48N/A--1
    No revisions (30d)
    -
    Jun 24
    Reported Jun 30
    -0.41N/AN/A-----
    Mar 24
    Reported May 15
    -0.38N/AN/A-----
    Dec 23
    Reported Mar 1
    -0.33N/AN/A-----

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-7.58xFCF Yield-13.19%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-47.80%ROIC-18.14%
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio67.79xQuick Ratio67.79x
    Trading Statistics
    Beta2.84Avg Volume86.19K
    52-Week High$14.9152-Week Low$1.91

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 33.4% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 21.7, below 30, the oversold line.

    Moving Averages

    SMA 10$2.16
    SMA 20$2.39
    SMA 50$2.90
    SMA 200$3.76
    EMA 10$2.14
    EMA 20$2.35
    EMA 50$2.73
    EMA 200$4.42

    MACD

    Line: -0.27Signal: -0.24Hist: -0.03

    ADX

    ADX: 46.2+DI: 6.9-DI: 33.8

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down100.0
    PSAR$2.50

    Bollinger Bands

    Upper Band$2.96
    Lower Band$1.81
    %B Position4812%(Upper)
    Band Width0.10

    RSI (14-Day)

    Oversold
    21.7

    Momentum Oscillators

    Stoch %K6.0
    Stoch %D5.6
    Williams %R-96.6
    ROC (10d)-18.9%
    Momentum-0.45
    CCI (20d)-126.2
    MFI (14d)12.8

    Volatility Measures

    ATR (14d)$0.17(8.8%)
    StdDev (20d)0.29
    Hist Vol57.5%(High)

    Volume Flow

    VWAP$1.95
    OBV2.0B
    AD Line4414.7B
    CMF (20d)-0.387

    Volume Metrics

    Avg Vol (20d)87.1K
    Vol Ratio1.3x
    VWMA (20d)$2.31

    Pivot Points

    R3$2.22
    R2$2.14
    R1$2.06
    Pivot Point$1.98
    S1$1.90
    S2$1.82
    S3$1.74

    Advanced Oscillators

    TSI-50.73
    Ultimate Osc30.4
    KST-274.16

    Financial Data

    QuarterSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total Revenue$0N/A$0$0$0$66.62K$0$12.00K$74.00K$12.00K$0$0
    Cost of Revenue$0N/A$0$0$0$179.82K$0$0$0$17.00K$0$0
    Gross Profit$0N/A$0$0$0N/A$0$12.00K$74.00K$12.00K$0$0
    Operating Expenses$3.44M$5.19M$4.05M$7.00M$6.79M$7.53M$5.00M$5.02M$6.33M$9.76M$7.42M$7.98M
    R&D$1.12M$1.49M$321.00K$2.28M$1.12M$3.70M$2.73M$1.41M$2.90M$4.36M$3.28M$2.64M
    SG&A$2.31M$3.70M$3.73M$4.71M$5.67M$3.83M$2.27M$3.60M$3.43M$5.41M$4.14M$5.34M
    Operating Income-$3.44M-$5.19M-$4.05M-$7.00M-$6.79M-$7.53M-$5.00M-$5.00M-$6.25M-$9.75M-$7.42M-$7.98M
    Interest Income$382.00K$5.00K-$38.00K$11.00K$11.00K$58.00K$4.00K$0$0$40.00K$75.00K$20.00K
    Interest ExpenseN/A$10.00K$0-$5.00K-$5.00K$534.00K$1.13M$143.00K-$28.00K$0$0$0
    Income Before Tax-$1.94M-$2.49M-$3.88M-$6.52M-$6.41M-$31.60M-$3.97M-$5.89M-$5.42M-$6.43M-$6.03M-$5.24M
    Income Tax Expense$0N/A$0$0$0$0$0$0$0$30.00K$0$0
    Net Income-$1.94M-$2.49M-$3.88M-$6.52M-$6.41M-$31.60M-$3.97M-$5.89M-$5.42M-$6.46M-$6.03M-$5.24M
    EBITDA-$2.32M-$2.44M-$3.78M-$6.48M-$6.35M-$31.07M-$2.85M-$5.63M-$5.38M-$6.41M-$6.09M-$5.23M
    EBIT-$2.32M-$2.49M-$3.85M-$6.54M-$6.42M-$31.13M-$2.85M-$5.75M-$5.45M-$6.47M-$6.11M-$5.25M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about IXHL

    News

    IXHL Valuation

    P/FCF
    -7.6x
    P/B
    0.4x
    All IXHL metrics

    IXHL Profitability: Margins, ROIC and FCF

    Incannex Healthcare (IXHL) has an operating margin of 0.0% and a net margin of 0.0%. It posts -18.1% ROIC.

    Operating margin
    0.0%
    Net margin
    0.0%
    ROIC
    -18.1%
    ROE
    -47.8%
    FCF yield
    -13.2%

    Incannex Healthcare Competitors

    The companies most similar to Incannex Healthcare (IXHL) include Scynexis, InMed Pharmaceuticals and Shuttle Pharmaceuticals.

    Sector: Healthcare

    Companies most similar to Incannex Healthcare

    IXHL Bull Case vs Bear Case

    Bear case

    • IXHL's quarterly revenue changed -100.0% year over year.

    IXHL Earnings: Next Report

    The next report from Incannex Healthcare (IXHL) is expected on Feb 11, 2027.

    Estimate revisions (30 days, fiscal period ending Dec 31, 2026)
    1 up, 0 down

    IXHL Earnings Date

    IXHL reports Feb 11, 2027. The date is estimated.

    Updated Nov 12, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About IXHL

    When does IXHL report earnings?

    Incannex Healthcare Inc. (IXHL) is expected to report earnings on Feb 11, 2027.

    Does IXHL pay dividends?

    Incannex Healthcare Inc. (IXHL) does not currently pay a regular dividend.

    What is IXHL's market cap?

    Incannex Healthcare Inc. (IXHL) has a market capitalization of $24.72M with a current stock price of $1.93.

    IXHL pages: Overview, Competitors

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.